Cargando…
Long non-coding RNA NORAD exhaustion represses prostate cancer progression through inhibiting TRIP13 expression via competitively binding to miR-495-3p
BACKGROUND: Prostate cancer (PCa) is a malignant heterogeneous tumor that threatens men’s health. Long non-coding RNA activated by DNA damage (NORAD) and microRNA-495-3p (miR-495-3p) have been revealed to be concerned with the tumorigenesis and progression of diverse cancers. Nevertheless, the regul...
Autores principales: | Chen, Fengling, Liu, Ling, Wang, Shuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368683/ https://www.ncbi.nlm.nih.gov/pubmed/32694945 http://dx.doi.org/10.1186/s12935-020-01371-z |
Ejemplares similares
-
Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway
por: Zhang, Yunxia, et al.
Publicado: (2020) -
NORAD-sponged miR-378c alleviates malignant behaviors of stomach adenocarcinoma via targeting NRP1
por: Hu, Yongjun, et al.
Publicado: (2022) -
High long non-coding RNA NORAD expression predicts poor prognosis and promotes breast cancer progression by regulating TGF-β pathway
por: Zhou, Ke, et al.
Publicado: (2019) -
Silencing TRIP13 inhibits cell growth and metastasis of hepatocellular carcinoma by activating of TGF-β1/smad3
por: Yao, Jianning, et al.
Publicado: (2018) -
Long non-coding RNA NORAD induces cell proliferation and migration in prostate cancer
por: Zhang, Haiyan, et al.
Publicado: (2019)